NYSE:ORB - Orbital Sciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Orbital Sciences Corporation develops and manufactures rockets and space systems for commercial, military and civil government customers, including the United States Department of Defense (DoD), the National Aeronautics and Space Administration (NASA), other Unites States Government agencies and commercial satellite operators. The Company operates in three segments, including launch vehicles, satellites and space systems, and advanced space programs. Launch Vehicles segment includes rockets that are used as space launch vehicles. Satellites and Space Systems segment satellites that are used to enable communications and broadcasting, conduct space-related scientific research, other deep-space exploration missions and demonstrate new space technologies. Advanced Space Programs segment includes human-rated space systems for Earth-orbit and deep-space exploration, and satellites used for national security space programs and to demonstrate new space technologies.

Receive ORB News and Ratings via Email

Sign-up to receive the latest news and ratings for ORB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryAerospace & Defense



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Orbital Sciences (NYSE:ORB) Frequently Asked Questions

What is Orbital Sciences' stock symbol?

Orbital Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "ORB."

Has Orbital Sciences been receiving favorable news coverage?

Media coverage about ORB stock has been trending somewhat positive recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Orbital Sciences earned a media sentiment score of 1.7 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an effect on the company's share price in the immediate future.

What other stocks do shareholders of Orbital Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orbital Sciences investors own include ANI Pharmaceuticals (ANIP), Altaba (AABA), ACADIA Pharmaceuticals (ACAD), Acorda Therapeutics (ACOR), Amgen (AMGN), Anacor Pharmaceuticals (ANAC), Ariad Pharmaceuticals (ARIA), Broadcom (AVGO), Biogen (BIIB) and Bio-Reference Laboratories (BRLI).

How do I buy shares of Orbital Sciences?

Shares of ORB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Orbital Sciences' official website?

The official website for Orbital Sciences is http://www.orbital.com/.

How can I contact Orbital Sciences?

Orbital Sciences' mailing address is 45101 Warp Dr, DULLES, VA 20166-6874, United States. The company can be reached via phone at +1-703-4065524.

MarketBeat Community Rating for Orbital Sciences (NYSE ORB)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  121 (Vote Outperform)
Underperform Votes:  121 (Vote Underperform)
Total Votes:  242
MarketBeat's community ratings are surveys of what our community members think about Orbital Sciences and other stocks. Vote "Outperform" if you believe ORB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ORB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel